Is Mistletoe Treatment Beneficial in Invasive Breast Cancer? A New Approach to an Unresolved Problem.

Background/aim: In this retrospective study, we compared breast cancer patients treated with and without mistletoe lectin I (ML-I) in addition to standard breast cancer treatment in order to determine a possible effect of this complementary treatment.

Patients And Methods: This study included 18,528 patients with invasive breast cancer. Data on additional ML-I treatments were reported for 164 patients.

Postoperative survival of lung cancer patients: are there predictors beyond TNM?

Background/aim: We report on survival data of 595 patients with stage I-III lung cancer with respect to TNM classification.

Materials And Methods: We constructed a basic model consisting of stage and grade, and assessed the improvement of survival prediction after adding comorbidity data, spirometric data, clinical and laboratory parameters.

Results: Body mass index (BMI) and presence of a cardiac disease reached statistical significance for prediction of overall survival in a Cox regression model.